-
Oil prices bounce back on Iran war escalation
-
Residents return to ravaged homes months after Hong Kong fire
-
Australia's Green wins playoff for third LPGA LA Championship title
-
Pakistan's military chief takes lead on US-Iran talks in diplomatic blitz
-
Thunder, Celtics open NBA playoffs with big wins, Magic shock Pistons
-
US begins Philippines war games in thick of Middle East conflict
-
Who's Bad? Not Michael Jackson in new big-budget biopic
-
Nations gather for first-ever conference on fossil fuel exit
-
Money, lobbyists, inertia: why fossil fuels are so hard to quit
-
France summons Elon Musk over X probe
-
'Save humanity': Four figures battling it out to lead embattled UN
-
Gilgeous-Alexander, Wemby, Jokic finalists for NBA MVP
-
Israel vows to level homes in Lebanon, counter threats with 'full force'
-
Rahm coasts to LIV Golf win in Mexico City
-
Fitzpatrick survives Scheffler playoff to win RBC Heritage
-
Thunder thrash Suns, Celtics crush Sixers in NBA playoff openers
-
Bulgaria's former president tops parliamentary vote
-
Kenyans Korir, Lokedi seek to repeat at Boston Marathon
-
AC Milan, Juventus close in on Champions League qualification
-
Spring double keeps Racing 92 in Top 14 play-off hunt with Paris derby win
-
Endrick stars as Lyon dent PSG's Ligue 1 title hopes
-
History haunts Arsenal as Man City take control of title race
-
AC Milan and Juventus close in on Champions League qualification
-
Celtics crush Sixers as Tatum and Brown shine in playoff opener
-
Guardiola warns title not won yet as Man City hunt down Arsenal
-
Arteta tells Arsenal to 'go again' in pursuit of Premier League title
-
Treble-chasing Bayern put beer showers on ice despite title win
-
Eight children dead in US domestic violence shooting
-
Arya, Connolly help Punjab hammer Lucknow in IPL
-
Man City beat Arsenal to seize control of title race, Liverpool win
-
Kane scores as Bayern sink Stuttgart to claim Bundesliga title
-
Balogun continues Monaco scoring streak, Rennes boost Champions League hopes
-
Trump orders negotiators to Pakistan, but Iran on the fence over talks
-
Haaland gives Man City edge over Arsenal in Premier League title showdown
-
Slot hails Liverpool mentality after last-gasp derby winner
-
Top boss vows 'no sitting still' as rugby bids to conquer US
-
Fils wins on Barcelona clay with French Open looming
-
'Super Mario Galaxy' rules N. America box office for third week
-
Liverpool snatch derby win ahead of City-Arsenal showdown
-
Evenepoel outsprints Skjelmose to win Amstel Gold Race
-
Liverpool beat Everton ahead of City-Arsenal showdown
-
Rabiot fires AC Milan past Verona to verge of Champions League return
-
UK PM vows to find arsonists of London Jewish sites
-
Rinku blitz leads Kolkata to first win of IPL season
-
Shelton wins fifth ATP title with victory in Munich
-
UK's Starmer to face grilling from MPs over Mandelson scandal
-
Trump again threatens Iran infrastructure as he orders negotiators to Pakistan
-
Rybakina outclasses Muchova to win Stuttgart WTA title
-
Blasi stuns field with victory in women's Amstel Gold Race
-
Pakistan tightens security in Islamabad ahead of US-Iran talks
Appetite-regulating hormones in focus as first Nobel Prizes fall
Research into hormones that regulate appetite is seen leading the race for the Nobel Prize in Medicine, to be awarded Monday -- the first in this year's Nobel season.
At a time when more than one billion people suffer from obesity, research into the hormone called "glucagon-like peptide 1" (GLP-1) could be given the nod for the Nobel Prize in Physiology or Medicine this year, experts said.
A new generation of drugs using GLP-1 agonists -- including blockbuster brands Ozempic, Wegovy and Mounjaro -- has provided a valuable tool to fight obesity and diabetes globally.
"Many are guessing that it (the Nobel Prize in Medicine) will go to the people behind GLP-1," Lars Brostrom, science editor at public broadcaster Sveriges Radio, told AFP.
That could help researchers from major US institutions once again dominate the Nobel Prizes in sciences, which are to be announced this week in Stockholm.
But, even if that happens, US politics is to cast a shadow over them, given budget cuts to science programmes ordered by President Donald Trump's government.
Since January, the US National Institutes of Health (NIH) has terminated 2,100 research grants totalling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch.
Such cuts could fuel debate over the growing risk that the United States could lose its edge in scientific research.
"In the post-war period, the US has taken over Germany's role as the world's leading scientific nation," Hans Ellegren, secretary general of the Royal Swedish Academy of Sciences, which awards Nobel Prizes in physics, chemistry, and economics, told AFP.
"When they now start cutting research funding, it threatens the country's position."
- Many contenders -
When it comes to GLP-1, as with many other discoveries, it can be hard to narrow down who exactly deserves to be honoured when many scientists around the world have made significant contributions.
Brostrom said some names often speculated upon are Danish physician Jens Juul Holst, and Joel Habener, a professor of medicine at Harvard, as well as Canadian endocrinologist Daniel Drucker and Yugoslav-born American chemist Svetlana Mojsov.
Despite treatments such as Ozempic being recently introduced, and the Nobel Assembly at the Karolinska Institute more often honouring discoveries that are decades old, "it could also be perfect timing" for GLP-1 recognition "because the discovery itself was made back in the 80s", Brostrom said.
In the same field, research on ghrelin, a hormone that stimulates appetite, could earn a Nobel Prize for two Japanese researchers, Kenji Kangawa and Masayasu Kojima, according to David Pendlebury, who heads research analysis at the firm Clarivate -- which predicts potential Nobel winners based on the number of citations of their work.
Pendlebury said that would also form "a nice bookend to a 1994 discovery" by geneticist Jeffrey Friedman, who discovered another appetite-regulating hormone, leptin, and who has previously been spotlighted by Clarivate.
"We have a combination of very nice discoveries, a hormone for appetite, a hormone that suppresses appetite, and this may also play into a lot of speculation of a prize for the GLP-1," he told AFP.
Clarivate also said the work of German medical professor Andrea Ablasser, American virologist Glen N. Barber, and Chinese-American biochemist Zhijian "James" Chen could be honoured "for elucidating the cGAS-STING pathway, a fundamental mechanism of innate immunity".
It noted that Canadian biologist John E. Dick could also be a contender "for identifying leukaemia stem cells and establishing their relevance in therapy failure".
- 'Invisibility cloak' -
For the Nobel Prize in Physics on Tuesday, experts at Sweden's public radio cited research into metamaterials, which has been buzzed about for several years.
British physicist John B. Pendry has in particular been frequently mentioned for his "invisibility cloak" -- a theoretical method to redirect electromagnetic fields around an object.
The Nobel season continues Wednesday with the prize for chemistry, followed on Thursday by the closely watched literature prize and on Friday the peace prize, which Donald Trump has argued should go to him.
The economics prize wraps up the Nobel season on October 13.
In addition to each honour, the prize includes a diploma, a gold medal, and a check for 11 million Swedish kronor ($1.2 million).
J.Williams--AMWN